stella
beta
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD — Stella
Home
/
Primary Hyperoxaluria Type 1
/
View on ClinicalTrials.gov
Recruiting
Back to Primary Hyperoxaluria Type 1 trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(18 sites)
United States
Clinical Trial Site, San Francisco, California
Clinical Trial Site, Boston, Massachusetts
Clinical Trial Site, Rochester, Minnesota
Clinical Trial Site, New York, New York
France
Clinical Trial Site, Bron
Clinical Trial Site, Paris
Germany
Clinical Trial Site, Bonn
Clinical Trial Site, Heidelberg
Italy
Clinical Trial Site, Roma
Lebanon
Clinical Trial Site, Beirut
Morocco
Clinical Trial Site, Casablanca
Romania
Clinical Trial Site, Oradea
Clinical Trial Site, Oradea
Spain
Clinical Trial Site, Barcelona
Clinical Trial Site, Santa Cruz de Tenerife
United Arab Emirates
Clinical Trial Site, Dubai
United Kingdom
Clinical Trial Site, London
Clinical Trial Site, London